Orgenesis EV 2011-2026 | ORGS

EV Jährlich Orgenesis

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
49.2 M	63.7 M	92.2 M	124 M	167 M	91.9 M	78 M	53.7 M	58.9 M	29.9 M	34.4 M	35.6 M	956 K

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert	Mindestwert	Durchschnitt
167 M	956 K	67.6 M

EV anderer Aktien in der Pharmaeinzelhändler

Name	EV	Preis	% 24h	Marktkapitalisierung	Land
MorphoSys AG MOR	1.82 B	-	2.43 %	$ 254 M	Germany
AbCellera Biologics ABCL	1.22 B	$ 3.52	-0.85 %	$ 1.05 B	Canada
ARCA biopharma ABIO	436 M	-	1052.0 %	$ 415 M	USA
Acorda Therapeutics ACOR	-13.2 M	-	-24.86 %	$ 820 K	USA
Acasti Pharma ACST	24 M	-	4.01 %	$ 150 M	Canada
AC Immune SA ACIU	82.4 M	$ 3.09	-6.93 %	$ 229 M	Schweiz
Adagene ADAG	395 M	$ 3.94	0.77 %	$ 222 M	China
I-Mab IMAB	8.28 B	-	-	$ 866 M	China
Advaxis ADXS	-3.02 M	-	-9.65 %	$ 45.9 M	USA
Alexion Pharmaceuticals, Inc. ALXN	1.95 B	-	-	$ 40.3 B	USA
Biophytis SA BPTS	525 M	-	-13.47 %	$ 169 M	France
AgeX Therapeutics AGE	6.28 M	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	-23.2 M	-	-	$ 1.01 B	USA
Aeterna Zentaris AEZS	5.52 M	-	5.93 %	$ 314 M	Canada
EyeGate Pharmaceuticals, Inc. EYEG	3.41 B	-	-1.52 %	$ 24.7 M	USA
ADC Therapeutics SA ADCT	114 M	$ 4.01	-2.2 %	$ 105 M	Schweiz
Applied Genetic Technologies Corporation AGTC	-9.16 M	-	-	$ 26.5 M	USA
Akouos AKUS	95.1 M	-	0.23 %	$ 488 M	USA
Midatech Pharma plc MTP	4.79 M	-	-18.52 %	$ 27.3 M	Britain
Allena Pharmaceuticals ALNA	-14.1 M	-	3.16 %	$ 1.9 M	USA
Ascendis Pharma A/S ASND	849 M	$ 227.41	-0.29 %	$ 5 B	Danmark
Aileron Therapeutics ALRN	33.1 M	-	10.36 %	$ 9.8 M	USA
Adverum Biotechnologies ADVM	125 M	-	-	$ 86.2 M	USA
Aptorum Group Limited APM	9.45 M	$ 0.78	-0.41 %	$ 4.25 M	China
Akero Therapeutics AKRO	2.99 B	-	-	$ 3.67 B	USA
argenx SE ARGX	-796 M	$ 684.77	-3.01 %	$ 25 B	Niderland
Институт стволовых клеток человека ISKJ	14.1 M	-	-	-	Russia
Albireo Pharma ALBO	417 M	-	-0.23 %	$ 916 M	USA
Acer Therapeutics ACER	38.2 M	-	2.71 %	$ 14 M	USA
Alterity Therapeutics Limited ATHE	-28.9 M	$ 3.5	4.78 %	$ 8.42 B	Australia
Autolus Therapeutics plc AUTL	1.11 B	$ 1.45	-3.97 %	$ 370 M	Britain
AlloVir ALVR	-55.1 M	-	4.14 %	$ 49.1 M	USA
Anika Therapeutics ANIK	300 M	$ 14.11	-2.76 %	$ 207 M	USA
Aptinyx APTX	-18.3 M	-	-39.0 %	$ 4.57 M	USA
BioCardia BCDA	12.4 M	$ 1.23	-3.91 %	$ 26.1 M	USA
BeiGene, Ltd. BGNE	-720 M	-	0.49 %	$ 251 B	Cayman-islands
Applied Molecular Transport AMTI	7.6 M	-	-	$ 10.1 M	USA
Bellerophon Therapeutics BLPH	77.1 M	-	-74.18 %	$ 955 K	USA
BioNTech SE BNTX	-4.91 B	$ 90.0	-5.12 %	$ 27.2 B	Germany
Aptose Biosciences APTO	10.8 M	-	-45.71 %	$ 1.2 M	Canada
Baudax Bio BXRX	29.8 M	-	0.59 %	$ 63 K	USA
Cara Therapeutics CARA	71.1 M	-	-3.03 %	$ 260 M	USA
Can-Fite BioPharma Ltd. CANF	647 M	$ 3.44	0.29 %	$ 7.49 B	Israel
Arcturus Therapeutics Holdings ARCT	43.4 M	$ 6.55	2.5 %	$ 179 M	Israel
Catalyst Biosciences CBIO	986 M	$ 10.35	-6.76 %	$ 925 M	USA
Burford Capital Limited BUR	3.22 B	$ 8.22	-0.72 %	$ 1.36 B	Britain
CureVac N.V. CVAC	3.19 B	-	-	$ 867 M	Germany
Aravive ARAV	58.2 M	-	-13.39 %	$ 1.45 M	USA
Athira Pharma ATHA	-18.3 M	-	-	$ 269 M	USA
Athersys ATHX	-37.4 M	-	3.77 %	$ 22.4 M	USA